Related references
Note: Only part of the references are listed.The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome
Maen D. Abou Ziki et al.
NUTRITION RESEARCH (2019)
The epidemiology of obesity
Yu Chung Chooi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
THE ASSOCIATION BETWEEN FIRST-DEGREE FAMILY HISTORY OF DIABETES AND METABOLIC SYNDROME
Xiang Hu et al.
ENDOCRINE PRACTICE (2019)
Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E
Maren Carstensen-Kirberg et al.
PLOS ONE (2019)
Homeostasis Model Assessment cut-off points related to metabolic syndrome in children and adolescents: a systematic review and meta-analysis
Paola Arellano-Ruiz et al.
EUROPEAN JOURNAL OF PEDIATRICS (2019)
Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease
Shan Tong et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives
Paul Weihe et al.
CURRENT OBESITY REPORTS (2019)
The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus
Ling-Bin Liu et al.
BIOSCIENCE REPORTS (2018)
The Global Epidemic of the Metabolic Syndrome
Mohammad G. Saklayen
CURRENT HYPERTENSION REPORTS (2018)
Plasma Sfrp5 and adiponectin levels in relation to blood pressure among obese children
C. Yin et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Family history of type 2 diabetes, abdominal adipocyte size and markers of the metabolic syndrome
P. Anthanont et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Metabolic Syndrome: Clinical and Policy Implications of the New Silent Killer
Dawn Harris Sherling et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
Wnt signaling in cardiovascular disease: opportunities and challenges
Austin Gay et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults
Qiuyan Xu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study
Maren Carstensen-Kirberg et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Relationship between homeostasis model assessment of insulin resistance and beta cell function and serum 25-hydroxyvitamin D in non-diabetic Korean adults
Hyun Yoon et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2016)
Metabolic Syndrome in Children and Adolescents
Chrystal Wittcopp et al.
PEDIATRICS IN REVIEW (2016)
Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study
Asghar Ghasemi et al.
ACTA DIABETOLOGICA (2015)
Declined plasma sfrp5 concentration in patients with type 2 diabetes and latent autoimmune diabetes in adults
Liqing Cheng et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2015)
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Un Ju Jung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Effect of Sfrp5 on Cytokine Release and Insulin Action in Primary Human Adipocytes and Skeletal Muscle Cells
Maren Carstensen et al.
PLOS ONE (2014)
Biochemistry of adipose tissue: an endocrine organ
Marisa Coelho et al.
ARCHIVES OF MEDICAL SCIENCE (2013)
Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance
Zhenping Hu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus
Yung-Chuan Lu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2013)
Characterization of the Wnt Inhibitors Secreted Frizzled-Related Proteins (SFRPs) in Human Adipose Tissue
Anna Ehrlund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition
Hiroyuki Mori et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Metabolic syndrome: definitions and controversies
Eva Kassi et al.
BMC MEDICINE (2011)
Utility of Homeostasis Model Assessment of beta-Cell Function in Predicting Diabetes in 12,924 Healthy Koreans
Ki-Chul Sung et al.
DIABETES CARE (2010)
Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity
Noriyuki Ouchi et al.
SCIENCE (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
The metabolic syndrome in children and adolescents - an IDF consensus report
Paul Zimmet et al.
PEDIATRIC DIABETES (2007)
Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China
Y. Wang et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Share Paper
